Bard Associates
ASST icon

Bard Associates’s Strive Inc ASST Stock Holding History

Bard Associates’s Portfolio ASST Stock Details ASST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$295 Buy
+10
New +$186 ﹤0.01% 328

Other funds holding ASST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Interchange Capital Partners
Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Bard Associates's ASST Position: Q3 2026 in Review

Bard Associates opened a new position in Strive Inc (ASST) in Q3 2026: 10 shares worth $295. The stake represents ﹤0.01% of the portfolio and ranks #328 among its holdings.

148 funds tracked by Wall St. Rank hold ASST as of Q3 2026.

  • Bard Associates held 10 shares of Strive Inc worth $295 as of Q3 2026.
  • Strive Inc was a new Bard Associates position in Q3 2026.
  • Strive Inc made up ﹤0.01% of Bard Associates's portfolio in Q3 2026, its #328 holding.
  • 148 funds tracked by Wall St. Rank held Strive Inc as of Q3 2026.

Based on Bard Associates's 13F filing for Q3 2026, filed 13 Nov 2026.